Human Cancer Protein-Protein Interaction Network: A Structural Perspective
Open accessThe DOI matches its Crossref record; 82 of the 83 references it cites were found in a registry or an index.
Abstract
Protein-protein interaction networks provide a global picture of cellular function and biological processes. Some proteins act as hub proteins, highly connected to others, whereas some others have few interactions. The dysfunction of some interactions causes many diseases, including cancer. Proteins interact through their interfaces. Therefore, studying the interface properties of cancer-related proteins will help explain their role in the interaction networks. Similar or overlapping binding sites should be used repeatedly in single interface hub proteins, making them promiscuous. Alternatively, multi-interface hub proteins make use of several distinct binding sites to bind to different partners. We propose a methodology to integrate protein interfaces into cancer interaction networks (ciSPIN, cancer structural protein interface network). The interactions in the human protein interaction network are replaced by interfaces, coming from either known or predicted complexes. We provide a detailed analysis of cancer related human protein-protein interfaces and the topological properties of the cancer network. The results reveal that cancer-related proteins have smaller, more planar, more charged and less hydrophobic binding sites than non-cancer proteins, which may indicate low affinity and high specificity of the cancer-related interactions. We also classified the genes in ciSPIN according to phenotypes. Within phenotypes, for breast cancer, colorectal cancer and leukemia, interface properties were found to be discriminating from non-cancer interfaces with an accuracy of 71%, 67%, 61%, respectively. In addition, cancer-related proteins tend to interact with their partners through distinct interfaces, corresponding mostly to multi-interface hubs, which comprise 56% of cancer-related proteins, and constituting the nodes with higher essentiality in the network (76%). We illustrate the interface related affinity properties of two cancer-related hub proteins: Erbb3, a multi interface, and Raf1, a single interface hub. The results reveal that affinity of interactions of the multi-interface hub tends to be higher than that of the single-interface hub. These findings might be important in obtaining new targets in cancer as well as finding the details of specific binding regions of putative cancer drug candidates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Representation of PIN,SPIN and iSPIN. In A) proteins in PIN are represented; the ones colored black have PDB IDs and the ones colored blue do not have PDB IDs. In B) The proteins with PDB ID and interactions among them constitutes SPIN. In C) The proteins with PDB ID and protein interface information and their interactions constitutes iSPIN. The zoomed representations give idea about what type of information each network contains; PIN is an abstract representation of interactions, SPIN is a subset of PIN with information of PDB IDs, and iSPIN contains the most detailed information including protein interfaces into network. All the networks are visualized using Cytoscape [76].](https://figures.cochat.ai/paper-figures/2bf731c1fa9c4785ae1df0d0e817ce26/human-cancer-protein-protein-interaction-network-a-structural-perspective-figure-1.jpg)






![Figure 8 Representation of ERBB3-NRG1 interaction schematically. The interactions are visualised using VMD [78] A) ERBB3 (1m6b_A) and NRG1 (1hae_A) are shown as newcartoon diagram in blue and red color, respectively. The transparent surface represents the interface region. The labeled residues (represented by their Cα atoms) of 1hae_A are reported to be critical for binding in a previous work [58]; i.e. when they are mutated to alanine, the binding affinity for ERBB3 was significantly reduced. B) HER3 (blue) – pertuzumab heavy chain (yellow) is shown. Pertuzumab shares the same interface with NRG1 (see “An inhibitor affecting Erb signaling pathway: pertuzumab” section).](https://figures.cochat.ai/paper-figures/57ca480593bb41beab9a8e93528906ac/human-cancer-protein-protein-interaction-network-a-structural-perspective-figure-8.jpg)



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Moreover, cancer-related proteins often interface with their binding partners using distinct surfaces, corresponding typically to multi-interface hub [21].”
From The design and development of covalent protein-protein interaction inhibitors for cancer treatment (2020) · cites this paper as [21]
In the citing paper
“Deeper investigations of protein-protein interfaces relevant to human oncogenesis and cancer-associated protein-protein interaction networks have shown that cancer-related proteins are smaller, more planar, more charged, and less hydrophobic binding sites than non-cancer-related proteins and they tend to show lower affinity and higher specificity for cancer-associated PPI networks.”
From The design and development of covalent protein-protein interaction inhibitors for cancer treatment (2020) · cites this paper as [21]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Gapped BLAST and PSI-BLAST: a new generation of protein database search programs
Altschul, S. (1997) · Nucleic Acids Research · doi:10.1093/nar/25.17.3389 · Cited by 73,302 · cited 1×
“They used an orthology-based method in which BLAST [65] searches were run for the human genome against all proteins in the DIP [59] and MIPS Mammalian Protein-Protein Interaction databases [66].”
MethodVMD: visual molecular dynamics
Humphrey, W., Dalke, A., & Schulten, K. (1996) · Journal of Molecular Graphics · doi:10.1016/0263-7855(96)00018-5 · Cited by 66,952 · cited 1×
“The interactions are visualised using VMD [78] A) ERBB3 (1m6b_A) and NRG1 (1hae_A) are shown as newcartoon diagram in blue and red color, respectively.”
MethodCytoscape: A software Environment for integrated models of biomolecular interaction networks
Shannon, P., Markiel, A., Ozier, O., Baliga, N. S., Wang, J. T., Ramage, D., Amin, N., Schwikowski, B., & Ideker, T. (2003) · Genome Research · doi:10.1101/gr.1239303 · Cited by 51,888 · cited 1×
“All the parameters describing the network topology were calculated using NetworkAnalyzer, which is a Java plugin for Cytoscape [76].”
MethodBerman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
KEGG: Kyoto Encyclopedia of Genes and Genomes
Kanehisa, M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.27 · Cited by 37,077 · cited 2×
“According to the KEGG database [56], ERBB3 functions in the ErbB signaling pathway and the Calcium signaling pathway.”
BackgroundMethodKEGG: Kyoto Encyclopedia of Genes and Genomes
Ogata, H., Goto, S., Sato, K., Fujibuchi, W., Bono, H., & Kanehisa, M. (1999) · Nucleic Acids Research · doi:10.1093/nar/27.1.29 · Cited by 31,232
Community structure in social and biological networks
Girvan, M., & Newman, M. E. J. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122653799 · Cited by 15,502 · cited 1×
“Betweenness is a measure of the total number of shortest paths going through a certain node or edge in the network [69].”
BackgroundNetwork biology: understanding the cell's functional organization
Barabási, A.-L., & Oltvai, Z. N. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1272 · Cited by 7,903 · cited 3×
“In Figure 2B, the average clustering coefficient, which is a measure of proteins to form clusters in the network [42] is shown.”
BackgroundInfluentialAn automated method for finding molecular complexes in large protein interaction networks
Bader, G. D., & Hogue, C. W. (2003) · BMC Bioinformatics · doi:10.1186/1471-2105-4-2 · Cited by 6,072 · cited 2×
“Here, we performed a clustering analysis of SPIN using MCODE [44] and obtained subnetworks (see Methods).”
MethodLethality and centrality in protein networks
Jeong, H., Mason, S. P., Barabási, A.-L., & Oltvai, Z. N. (2001) · Nature · doi:10.1038/35075138 · Cited by 5,287
Cited by
Structure and dynamics of molecular networks: A novel paradigm of drug discovery
Csermely, P., Korcsmáros, T., Kiss, H. J. M., London, G., & Nussinov, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.016 · Cited by 892
“Cancer-related proteins have smaller, more planar, more charged and less hydrophobic binding interfaces than other proteins, which may indicate low affinity and high specificity of cancer-related interactions (Kar et al., 2009).”
BackgroundPredicting Protein–Protein Interactions from the Molecular to the Proteome Level
Keskin, O., Tuncbag, N., & Gursoy, A. (2016) · Chemical Reviews · doi:10.1021/acs.chemrev.5b00683 · Cited by 369
ATM-Dependent and -Independent Dynamics of the Nuclear Phosphoproteome After DNA Damage
Bensimon, A., Schmidt, A., Ziv, Y., Elkon, R., Wang, S.-Y., Chen, D. J., Aebersold, R., & Shiloh, Y. (2010) · Science Signaling · doi:10.1126/scisignal.2001034 · Cited by 280
“Most of the nodes in this network had only few edges, whereas a few nodes, termed “hubs,” had more edges than the average and probably represent key players (50, 51, 53).”
BackgroundTuncbag, N., Gursoy, A., Nussinov, R., & Keskin, O. (2011) · Nature Protocols · doi:10.1038/nprot.2011.367 · Cited by 263
“PRISM has been used in several studies including comparison of physicochemical properties of cancer-related protein complexes on a large scal”
MethodHive plots--rational approach to visualizing networks
Krzywinski, M., Birol, I., Jones, S. J., & Marra, M. A. (2012) · Briefings in Bioinformatics · doi:10.1093/bib/bbr069 · Cited by 224
“[5, 17].”
BackgroundControllability in protein interaction networks
Wuchty, S. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1311231111 · Cited by 210
“In humans, human viruses and parasites target certain proteins to seize control of a host cell (8, 9) whereas such proteins play a decisive role in different cancer types (10, 11).”
BackgroundAllostery and population shift in drug discovery
Kar, G., Keskin, O., Gursoy, A., & Nussinov, R. (2010) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2010.09.002 · Cited by 187
“on the proteome scale, to construct pathways [41] and characterize networks [42].”
Self-citationRevisiting Date and Party Hubs: Novel Approaches to Role Assignment in Protein Interaction Networks
Agarwal, S., Deane, C. M., Porter, M. A., & Jones, N. S. (2010) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1000817 · Cited by 139
“However, despite (or in some cases due to) this ongoing debate, the hypothesis has been highly prominent in the literature [2,7–15].”
ResultLearning spatial structures of proteins improves protein–protein interaction prediction
Song, B., Luo, X., Luo, X., Liu, Y., Niu, Z., & Zeng, X. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbab558 · Cited by 133
Drug Target Protein-Protein Interaction Networks: A Systematic Perspective
Feng, Y., Wang, Q., & Wang, T. (2017) · BioMed Research International · doi:10.1155/2017/1289259 · Cited by 118
“It implies that the proteins have a lower tendency to form clusters [42].”
BackgroundCancer Missense Mutations Alter Binding Properties of Proteins and Their Interaction Networks
Nishi, H., Tyagi, M., Teng, S., Shoemaker, B. A., Hashimoto, K., Alexov, E., Wuchty, S., & Panchenko, A. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066273 · Cited by 117
“Indeed, although oncogenes were reported to have a certain tendency to cluster into a small number of modules and pathways [60,61], other reports did not confirm such characteristics [16].”
BackgroundInfluentialVilloutreix, B. O., Kuenemann, M. A., Poyet, J., Bruzzoni‐Giovanelli, H., Labbé, C., Lagorce, D., Sperandio, O., & Miteva, M. A. (2014) · Molecular Informatics · doi:10.1002/minf.201400040 · Cited by 116
Quantitative proteomics in lung cancer
Cheung, C. H. Y., & Juan, H. (2017) · Journal of Biomedical Science · doi:10.1186/s12929-017-0343-y · Cited by 123
“The dysfunction of protein-protein interactions is one of the causes for many diseases, including cancer [67].”
BackgroundKaake, R. M., Wang, X., & Huang, L. (2010) · Molecular & Cellular Proteomics · doi:10.1074/mcp.r110.000265 · Cited by 101
Labbé, C. M., Laconde, G., Kuenemann, M. A., Villoutreix, B. O., & Sperandio, O. (2013) · Drug Discovery Today · doi:10.1016/j.drudis.2013.05.003 · Cited by 104
Protein–protein interaction networks and subnetworks in the biology of disease
Nibbe, R. K., Chowdhury, S. A., Koyutürk, M., Ewing, R. M., & Chance, M. R. (2010) · WIREs Systems Biology and Medicine · doi:10.1002/wsbm.121 · Cited by 104
He, S., Senter, T. J., Pollock, J., Han, C., Upadhyay, S. K., Purohit, T., Gogliotti, R. D., Lindsley, C. W., Cierpicki, T., Stauffer, S. R., et al. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm401868d · Cited by 99
The design and development of covalent protein-protein interaction inhibitors for cancer treatment
Cheng, S.-S., Yang, G.-J., Wang, W., Leung, C.-H., & Ma, D.-L. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00850-0 · Cited by 98
“Moreover, cancer-related proteins often interface with their binding partners using distinct surfaces, corresponding typically to multi-interface hub [21].”
BackgroundPeng, W., Wang, J., Cheng, Y., Lu, Y., Wu, F., & Pan, Y. F. (2014) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2014.2338317 · Cited by 100
“constructs structural network, based on which a series of research works are carried out, such as analyzing human disease [36], [37], explaining the relationship between hub proteins and their essentiality [38], constructing signal pathway [39] and so on.”
BackgroundTowards a detailed atlas of protein–protein interactions
Mosca, R., Pons, T., Ceol, A. G. M., Valencia, A., & Aloy, P. (2013) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2013.07.005 · Cited by 103
Araya, C. L., Cenik, C., Reuter, J., Kiss, G., Pande, V. S., Snyder, M. P., & Greenleaf, W. J. (2015) · Nature Genetics · doi:10.1038/ng.3471 · Cited by 89
From Laptop to Benchtop to Bedside: Structure-based Drug Design on Protein Targets
Chen, L., K. Morrow, J., T. Tran, H., S. Phatak, S., Du-Cuny, L., & Zhang, S. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212799436386 · Cited by 78
Borkin, D., Pollock, J., Kempinska, K., Purohit, T., Li, X., Wen, B., Zhao, T., Miao, H., Shukla, S., He, M., et al. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01305 · Cited by 76
“6-Hydroxy-5-((4-((6-(2,2,2-trifluoroethyl)thieno[2,3-d]-pyrimidin-4yl)amino)piperidin-1-yl)methyl)-1H-indole-2-carbonitrile (17)—Similar procedure was used as for 20 but starting with 50 mg (0.”
MethodKumar, R., Verma, H., Haider, S., Bajaj, A., Sood, U., Ponnusamy, K., Nagar, S., Shakarad, M., Negi, R. K., Singh, Y. P., et al. (2017) · mSystems · doi:10.1128/msystems.00020-17 · Cited by 74
“Protein-protein interaction (PPI) networks enable biological characteristics and protein function to be taken into consideration for each strain (26) and can be used to identify habitat-specific adaptations (27).”
BackgroundSudha, G., Nussinov, R., & Srinivasan, N. (2014) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2014.07.004 · Cited by 73
The role of protein disorder in the 14-3-3 interaction network
Bustos, D. M. (2011) · Molecular BioSystems · doi:10.1039/c1mb05216k · Cited by 78
Constructing structural networks of signaling pathways on the proteome scale
Kuzu, G., Keskin, Ö., Gürsoy, A., & Nussinov, R. (2012) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2012.04.004 · Cited by 65
Prediction of protein–protein interactions: unifying evolution and structure at protein interfaces
Tuncbag, N., Gursoy, A., & Keskin, O. (2011) · Physical Biology · doi:10.1088/1478-3975/8/3/035006 · Cited by 63
“This method is used to generate a structural interaction map of cancer proteins [111] and to show the multi-face nature of the hub proteins [112].”
MethodProtein interaction networks as metric spaces: a novel perspective on distribution of hubs
Fadhal, E., Gamieldien, J., & Mwambene, E. C. (2014) · BMC Systems Biology · doi:10.1186/1752-0509-8-6 · Cited by 65
“Background In the post-genomic era, an overarching question in the analysis of protein-protein interaction (PPI) networks continues to be whether biological characteristics and functions of proteins such as lethality, physiological malfunctions and malignancy are intimately linked to the topological role proteins play…”
BackgroundStructural Bioinformatics of the Interactome
Petrey, D., & Honig, B. (2014) · Annual Review of Biophysics · doi:10.1146/annurev-biophys-051013-022726 · Cited by 59
“…properties of a protein’s position in the interactome with its structural properties, finding that hub proteins have larger accessible area with mutations enriched on the surface (91), and that cancer-related proteins tend to interact with multiple partners at multiple interfaces (61, 86).”
BackgroundHuman Proteome-scale Structural Modeling of E2–E3 Interactions Exploiting Interface Motifs
Kar, G., Keskin, O., Nussinov, R., & Gursoy, A. (2012) · Journal of Proteome Research · doi:10.1021/pr2009143 · Cited by 55
Self-citationConformational ensembles, signal transduction and residue hot spots: application to drug discovery.
Acuner, S. E., Gürsoy, A., Keskin, Ö., & Nussinov, R. (2010) · PubMed · Cited by 65
Intrinsically disordered proteins and conformational noise: Implications in cancer
Mahmoudabadi, G., Rajagopalan, K., Getzenberg, R. H., Hannenhalli, S. S., Rangarajan, G., & Kulkarni, P. (2012) · Cell Cycle · doi:10.4161/cc.23178 · Cited by 55
Cierpicki, T., & Grembecka, J. (2015) · Immunological Reviews · doi:10.1111/imr.12244 · Cited by 53
“Overall, successful development of these compounds and their effect in functional assays suggest that CBFb-Runx1 inhibitors might have a potential therapeutic value, although their further development is required to identify compounds suitable for in vivo studies in animal models of inv(16) leukemia.”
BackgroundInfluentialGyurkó, D. M., Veres, D. V., Módos, D., Lenti, K., Korcsmáros, T., & Csermely, P. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.06.005 · Cited by 53
de Azevedo, H. F. Z., & Moreira‐Filho, C. A. (2015) · Scientific Reports · doi:10.1038/srep16830 · Cited by 52
Understanding cancer complexome using networks, spectral graph theory and multilayer framework
Rai, A., Pradhan, P., Nagraj, J., Lohitesh, K., Chowdhury, R., & Jalan, S. (2017) · Scientific Reports · doi:10.1038/srep41676 · Cited by 57
“Other PPI studies have also reported that most of the cancer proteins exhibit a higher binding tendency to interact with other proteins due to favorable mutations at binding sites [21].”
Exploiting Conformational Ensembles in Modeling Protein–Protein Interactions on the Proteome Scale
Kuzu, G., Gursoy, A., Nussinov, R., & Keskin, O. (2013) · Journal of Proteome Research · doi:10.1021/pr400006k · Cited by 47
Azodi, M. Z., Rezaei–Tavirani, M., Rahmati-Rad, S., Hasanzadeh, H., Tavirani, M. R., & Seyyedi, S. S. (2015) · Gastroenterology and hepatology from bed to bench. · Cited by 46
Structural Systems Pharmacology: The Role of 3D Structures in Next-Generation Drug Development
Duran‐Frigola, M., Mosca, R., & Aloy, P. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.03.004 · Cited by 51
Scanning Protein Surfaces with DNA‐Encoded Libraries
Kunig, V. B. K., Potowski, M., Škopić, M. K., & Brunschweiger, A. (2020) · ChemMedChem · doi:10.1002/cmdc.202000869 · Cited by 54
Tools for protein-protein interaction network analysis in cancer research
Pamplona, R. S., Berenguer, A., Solé, X., Cordero, D., Crous‐Bou, M., Serra-Musach, J., Guinó, E., Pujana, M. Á., & Moreno, V. R. (2012) · Clinical & Translational Oncology · doi:10.1007/s12094-012-0755-9 · Cited by 49
“signalling pathways, so they often work as protein hubs inside an interaction network [45].”
BackgroundSantana-Codina, N., Carretero, R., Pamplona, R. S., Cabrera, T., Güney, E., Oliva, B., Clézardin, P., Olarte, O. E., Loza‐Álvarez, P., Méndez‐Lucas, A., et al. (2013) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m112.022772 · Cited by 42
“hubs and they usually appear in networks with a high functional and topological centrality (45).”
BackgroundAnalysis of Hot Region Organization in Hub Proteins
Cukuroglu, E., Gürsoy, A., & Keskin, Ö. (2010) · Annals of Biomedical Engineering · doi:10.1007/s10439-010-0048-9 · Cited by 42
Feliu, E., Aloy, P., & Oliva, B. (2011) · Protein Science · doi:10.1002/pro.585 · Cited by 43
Protein interaction networks: centrality, modularity, dynamics, and applications
Meng, X., Li, W.-K., Peng, X., Li, Y., & Li, M. (2021) · Frontiers of Computer Science · doi:10.1007/s11704-020-8179-0 · Cited by 43
Tang, Y.-Q., Jaganath, I. B., Manikam, R., & Sekaran, S. D. (2013) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2013/609581 · Cited by 40
Stability and bifurcation of delay-coupled genetic regulatory networks with hub structure
Yue, D., Guan, Z., Li, J., Liu, F., Xiao, J., & Ling, G. (2019) · Journal of the Franklin Institute · doi:10.1016/j.jfranklin.2018.11.030 · Cited by 39
Fornili, A., Pandini, A., Lu, H.-C., & Fraternali, F. (2013) · Journal of Chemical Theory and Computation · doi:10.1021/ct400486p · Cited by 39
Khan, S., Sikander, M., Ebeling, M. C., Ganju, A., Kumari, S., Yallapu, M. M., Hafeez, B. B., Ise, T., Nagata, S., Zafar, N., et al. (2016) · Oncogene · doi:10.1038/onc.2016.218 · Cited by 38
Ardakani, M. J. E., Safaei, A., Oskouie, A. A., Haghparast, H., Haghazali, M., Shalmani, H. M., Peyvandi, H., Naderi, N., & Zali, M. R. (2016) · Gastroenterology and hepatology from bed to bench. · Cited by 39
Wang, C., Jiang, W., Li, W., Lian, B., Chen, X., Hua, L., Lin, H., Li, D., Li, X., & Liu, Z. (2010) · Journal of drug targeting · doi:10.3109/1061186x.2010.504261 · Cited by 36
“The drug targets that are regulated by miRNAs have high average degree and low average topological coefficient, which also supports the modular network organization (Kar et al., 2009).”
BackgroundEssential protein discovery based on a combination of modularity and conservatism
Zhao, B., Wang, J., Li, X., & Wu, F. (2016) · Methods · doi:10.1016/j.ymeth.2016.07.005 · Cited by 36
Cheng, L., Liu, P., Wang, D., & Leung, K. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-2598-7 · Cited by 33
Transcriptomic Signatures in Colorectal Cancer Progression
Ershov, P., Поярков, С. В., Konstantinova, Y., Veselovsky, E., & Makarova, A. S. (2022) · Current Molecular Medicine · doi:10.2174/1566524022666220427102048 · Cited by 33
Constructing the angiome: a global angiogenesis protein interaction network
Chu, L.-H., Rivera, C. G., Popel, A. S., & Bader, J. S. (2012) · Physiological Genomics · doi:10.1152/physiolgenomics.00181.2011 · Cited by 33
Rout, T., Mohapatra, A., & Kar, M. (2024) · Network Modeling Analysis in Health Informatics and Bioinformatics · doi:10.1007/s13721-024-00467-0 · Cited by 36
“The article discusses the construction of the cancer PPI network, identifying cancer-associated modules, and characterizing fundamental network properties (Kar et al. 2009).”
Nanaware, P. P., Ramteke, M. P., Somavarapu, A. K., & Venkatraman, P. (2013) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24494 · Cited by 31
“Gankyrin pBluescript II SK (1) construct (kind gift from Dr.”
BackgroundYan, W., Liu, X., Wang, Y., Han, S., Wang, F., Liu, X., Xiao, F., & Hu, G. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00534 · Cited by 32
“Additionally, the structural annotation of PPI networks that has highlighted key residues has enriched the fi elds of both systems biology and rational drug design (Kar et al., 2009; Winter et al., 2012).”
BackgroundKumar, A., Butler, B. M., Kumar, S., & Ozkan, S. B. (2015) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2015.11.002 · Cited by 33
“First, these studies showed that the pleiotropy of disease-associated nsSNVs can be explained by proteins interacting with different proteins at different interfaces [33], where the mutations at these separate interfaces may lead to different diseases and intensities [34 ].”
BackgroundAfonso, A. L., Cavaleiro, C. T., Castanho, M. A. R. B., Neves, V., & Cavaco, M. C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26073117 · Cited by 30
A systems biology analysis of autophagy in cancer therapy
Shi, Z., Li, C., Zhao, S., Yu, Y., An, N., Liu, Y.-X., Wu, C., Yue, B., & Bao, J. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.06.004 · Cited by 35
“the characteristics of each of the individual components [97].”
BackgroundZhou, B., Wu, Y., Cheng, P., & Wu, C. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13424 · Cited by 30
Kranthi, T., Rao, S. B., & Manimaran, P. (2013) · Molecular BioSystems · doi:10.1039/c3mb25589a · Cited by 31
A Strategy Based on Protein–Protein Interface Motifs May Help in Identifying Drug Off-Targets
Engin, H. B., Keskin, Ö., Nussinov, R., & Gürsoy, A. (2012) · Journal of Chemical Information and Modeling · doi:10.1021/ci300072q · Cited by 28
MicroRNA Regulation and Tissue-Specific Protein Interaction Network
Zhu, W., Yang, L., & Du, Z. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025394 · Cited by 27
Toward a three-dimensional view of protein networks between species
Franzosa, E. A., Garamszegi, S., & Xia, Y. (2012) · Frontiers in Microbiology · doi:10.3389/fmicb.2012.00428 · Cited by 27
“…of the within-species structural interaction networks have provided significant insights into a wide range of topics including biophysics, evolution, disease biology, and drug design (Kim et al., 2006, 2008; Franzosa and Xia, 2008, 2009; Kar et al., 2009; Xie et al., 2011; Wang et al., 2012).”
BackgroundOncodomains: A protein domain-centric framework for analyzing rare variants in tumor samples
Peterson, T. A., Gauran, I. I., Park, J., Park, D., & Kann, M. G. (2017) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005428 · Cited by 27
Hindumathi, V., Kranthi, T., Rao, S. B., & Manimaran, P. (2014) · Molecular BioSystems · doi:10.1039/c4mb00004h · Cited by 25
Protein–protein interaction networks studies and importance of 3D structure knowledge
Lu, H., Fornili, A., & Fraternali, F. (2013) · Expert Review of Proteomics · doi:10.1586/14789450.2013.856764 · Cited by 25
Core and specific network markers of carcinogenesis from multiple cancer samples
Wong, Y.-H., Chen, R.-H., & Chen, B. (2014) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2014.05.045 · Cited by 24
Interaction-based discovery of functionally important genes in cancers
Ghersi, D., & Singh, M. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt1305 · Cited by 25
Cancer networks and beyond: Interpreting mutations using the human interactome and protein structure
Gulati, S., Cheng, T. M. K., & Bates, P. A. (2013) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2013.05.002 · Cited by 23
Fernandes, L. P., Annibale, A., Kleinjung, J., Coolen, A. C. C., & Fraternali, F. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012083 · Cited by 23
“. Interaction maps (otherwise here named interactomes, referring to the entire set of molecular interactions in the cell) can reveal important mechanistic principles that may guide further progress in the understanding of cellular function, and of dysfunction leading to disease”
BackgroundVasconcelos, C. R. D. S., Campos, T. D. L., & Rezende, A. M. (2018) · BMC Bioinformatics · doi:10.1186/s12859-018-2105-6 · Cited by 24
“Protein interaction networks have been used in some studies with the objective of selecting promising therapeutic targets [29 – 31], and the protein interaction data contained in this type of network has already been used in the pharmaceutical industry to development of new drugs [32].”
MethodAnalysis of single amino acid variations in singlet hot spots of protein–protein interfaces
Özdemir, E. S., Gürsoy, A., & Keskin, Ö. (2018) · Bioinformatics · doi:10.1093/bioinformatics/bty569 · Cited by 25
Clique Identification in Signed Graphs: A Balance Theory Based Model
Sun, R., Wu, Y., Wang, X., Chen, C., Zhang, W., & Lin, X. (2023) · IEEE Transactions on Knowledge and Data Engineering · doi:10.1109/tkde.2023.3272636 · Cited by 22
Ju, H., Kim, K., Kim, B. I., & Woo, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25020698 · Cited by 24
“By annotating PPI interactions, the processes underlying tumor activities can be understood and potential therapeutic targets for diverse medical conditions can be identified [14].”
BackgroundPredicting the Binding Patterns of Hub Proteins: A Study Using Yeast Protein Interaction Networks
Andorf, C. M., Honavar, V., & Sen, T. Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056833 · Cited by 25
“Experimental characterization of hub proteins in terms of their structural and kinetic characteristics requires knowledge of the structures of complexes formed by such proteins in interaction with their binding partners [35,37].”
BackgroundAllosteric inhibition of Taspase1′s pathobiological activity by enforced dimerization in vivo
Bier, C., Knauer, S. K., Gül, D., Kunst, L., Scheiding, S., Kaiser, M., Ottmann, C., Krämer, O. H., & Stauber, R. H. (2012) · The FASEB Journal · doi:10.1096/fj.11-202432 · Cited by 25
Taspase1: a 'misunderstood' protease with translational cancer relevance
Wünsch, D., Hahlbrock, A., Jung, S., Schirmeister, T., van den Boom, J., Schilling, O., Knauer, S. K., & Stauber, R. H. (2015) · Oncogene · doi:10.1038/onc.2015.436 · Cited by 24
Kumar, G., Breen, E. J., & Ranganathan, S. (2013) · BMC Systems Biology · doi:10.1186/1752-0509-7-12 · Cited by 22
“It has also facilitated the understanding of living cells at a systemic level by linking molecules to biological functions and thus bridging the genotypeto-phenotype gap via understanding the organisation of biological pathways [3] and the network of protein interactions [4].”
BackgroundTzakos, A. G., Fokas, D., Johannes, C., Moussis, V., Hatzimichael, E. C., & Briasoulis, E. C. (2011) · Molecules · doi:10.3390/molecules16064408 · Cited by 23
“Recent work on network characteristics and interface properties of cancer-related proteins revealed a distinct trend in comparison to non-cancer proteins [49,50].”
BackgroundInfluentialComputational medicine: quantitative modeling of complex diseases
Tiwary, B. K. (2019) · Briefings in Bioinformatics · doi:10.1093/bib/bbz005 · Cited by 22
Proteome-wide Mendelian randomization identifies causal plasma proteins in lung cancer
Li, H., Du, S., Dai, J., Jiang, Y., Li, Z., Fan, Q., Zhang, Y., You, D., Zhang, R., Zhao, Y., et al. (2024) · iScience · doi:10.1016/j.isci.2024.108985 · Cited by 22
“10,11 Recently, proteomics-based risk model showed promise in predicting incident lung cancer.”
BackgroundLi, M., Zhang, J., Liu, Q., Wang, J., & Wu, F. (2014) · BMC Medical Genomics · doi:10.1186/1755-8794-7-s2-s4 · Cited by 22
Wang, F., Han, S., Ji, Y., Yan, W., & Hu, G. (2021) · Cells · doi:10.3390/cells10020402 · Cited by 21
“The wealth of structural knowledge in PPI networks can help to partially address this goal [34].”
BackgroundAre transient protein-protein interactions more dispensable?
Ghadie, M. A., & Xia, Y. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010013 · Cited by 19
“Hence, the collective network of PPIs, commonly known as the interactome network, has been imperative for our understanding of cell function [1,2], disease [3–7], and evolution [8–11], especially when combined with protein structural information [12–21].”
Dasgupta, B., Nakamura, H., & Kinjo, A. R. (2011) · Journal of Molecular Biology · doi:10.1016/j.jmb.2011.06.027 · Cited by 18
Huang, C., Peng, H.-S., & Ng, K. (2015) · BioMed Research International · doi:10.1155/2015/312047 · Cited by 18
Revisiting intracellular calcium signaling semantics
Haiech, J., Audran, E., Fève, M., Ranjeva, R., & Kilhoffer, M. (2011) · Biochimie · doi:10.1016/j.biochi.2011.05.003 · Cited by 18
Modeling Protein Assemblies in the Proteome
Kuzu, G., Keskin, Ö., Nussinov, R., & Gürsoy, A. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.031294 · Cited by 18
“In addition, we have shown that it can be used to model structural networks (57, 58).”
MethodComputational Prediction of Protein Complexes from Protein Interaction Networks
Srihari, S., Yong, C. H., & Wong, L. (2017) · doi:10.1145/3064650 · Cited by 19
Oviya, R. P., Gopisetty, G., Jayavelu, S., & Rajkumar, T. (2021) · The Journal of Biochemistry · doi:10.1093/jb/mvab004 · Cited by 20
Fadhal, E., Mwambene, E. C., & Gamieldien, J. (2014) · BMC Systems Biology · doi:10.1186/1752-0509-8-68 · Cited by 18
“A predominant question in the analysis of PINs continues to be whether biological characteristics and functions of proteins such as lethality, physiological malfunctions and malignancy are intimately linked to the topological role proteins play in the network [17-21].”
BackgroundDinçer, C., Kaya, T., Keskin, Ö., Gürsoy, A., & Tunçbağ, N. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006789 · Cited by 17
Interacting partners of FEN1 and its role in the development of anticancer therapeutics
Kathera, C., Zhang, J., Janardhan, A., Sun, H., Ali, W., Zhou, X., He, L., & Guo, Z. (2017) · Oncotarget · doi:10.18632/oncotarget.15176 · Cited by 16
“The disfunction of some PPI may cause many diseases, including cancer [8].”
BackgroundRout, T., Mohapatra, A., Kar, M., Patra, S., & Muduly, D. K. (2024) · Procedia Computer Science · doi:10.1016/j.procs.2024.04.260 · Cited by 16
Yin, J., Li, X., Li, F., Lu, Y., Zeng, S., & Zhu, F. (2021) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2021.04.035 · Cited by 15
“The ‘clustering coefficient’ denoted neighborhood connectivity [130], and the ‘clustering coefficient’ decreased with the increase in the number of interacting proteins [131].”
BackgroundKhan, A., Li, W., Ambreen, A., Wei, D., Wang, Y., & Mao, Y. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105537 · Cited by 15
Metadata
- Authors
- Kar, G., Gursoy, A., & Keskin, O.
- Affiliations
- Koç University (TR)
- ORCID
- Kar, Gozde
- Venue
- PLoS Computational Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-12-11
- Volume
- 5
- Issue
- 12
- Pages
- e1000601
- ISSN
- 1553-734X (ISSN-L)
- 1553-7358
- PMC
- PMC2785480
- OpenAlex
- W2150066952
- Cited by
- 235
- References
- 83
- Citations by year
- 2026: 3 · 2025: 10 · 2024: 12 · 2023: 13 · 2022: 10 · 2021: 12 · 2020: 7 · 2019: 17 · 2018: 9 · 2017: 26 · 2016: 12 · 2015: 12 · 2014: 18 · 2013: 28 · 2012: 17
- FWCI
- 6.18
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Computational Biology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Digital Collections portal (Koç University) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Türkiye Bilimsel ve Teknolojik Araştırma Kurumu (104T504)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bioinformatics and Genomic Networks
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- protein-protein interaction network, cancer-related proteins, protein interfaces, binding sites, hub proteins, network topology, binding affinity, binding specificity, breast cancer, colorectal cancer, leukemia, HER3, Raf-1, cancer drug targets
- MeSH terms
- Animals, Binding Sites, Humans, Models, Molecular, Neoplasms, Protein Binding, Proteins, Signal Transduction, Gene Expression Regulation, Neoplastic, Computational Biology, Protein Interaction Domains and Motifs, Hydrophobic and Hydrophilic Interactions
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.